Top Competitors of BSX in the Endoscopy Space Stryker ’s SYK Endoscopy segment posted strong growth in the first quarter, with U.S. organic sales rising 11.1%, driven by double-digit gains in ...

Boston Scientific Corporation (BSX)’s share was trading at $94.27 as of April 14th. BSX’s trailing and forward P/E were 75.42 and 33.11 respectively according to Yahoo Finance.

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands ...

Shares of BSX have also skyrocketed nearly 53.7% over the past 52 weeks, significantly outperforming XLV’s 1.4% gains over the same time frame.

PAHC currently has a forward P/E ratio of 13.32, while BSX has a forward P/E of 35.50. We also note that PAHC has a PEG ratio of 0.51. This metric is used similarly to the famous P/E ratio, but ...

“The launch of the new BSX technology platform represents an important milestone in our strategy to build and operate all our exchanges utilizing proprietary MIAX technology,” said Thomas P. Gallagher ...

Boston Scientific’s revenue climbed 32%, rising from $12.7 billion in 2022 to $16.7 billion in 2024, driven by an increase in total procedures and the introduction of new products such as POLARx ...

That was because the BSX has listed virtually every catastrophe bond that came to market in 2024. The number of catastrophe bond programme structures listed on the BSX rose from 108 to 114 over ...

The BSX hosted its bell-ringing ceremony at 9am as part of the annual Women’s Day event hosted by the Bermuda International Women’s Day Committee in partnership with the Women’s Resource Centre.